Cancer Research Technologist
Research Projects Coordinator
Naoto Nakamichi, PhD
Dr. Shrinka Sen, PhD
Ebrahim Eskandari Nasab
Laura Gonzalez Campos
Shu Xian Susanna Tan
Response to Comment on "PP2A inhibition sensitizes cancer stem cells to ABL tyrosine kinase inhibitors in BCR-ABL+ human leukemia".
Science translational medicine, 2019
Transcriptional regulation of normal human mammary cell heterogeneity and its perturbation in breast cancer.
The EMBO journal, 2019
Experimental hematology, 2019
Stem cells and development, 2019
A topological view of human CD34+ cell state trajectories from integrated single-cell output and proteomic data.
Stem cell reports, 2018
Plerixafor effectively mobilizes CD56bright NK cells in blood, providing an allograft predicted to protect against GVHD.
BC Cancer Foundation is the fundraising partner of BC Cancer, which includes BC Cancer Research. Together with our donors, we are changing cancer outcomes for British Columbians by funding innovative research and personalized treatment and care.